MFG
ZSAN

Magnus Financial Group’s Zosano Pharma Corporation ZSAN Stock Holding History

Magnus Financial Group’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-286
Closed -$5K – 372
2020
Q4 		$5K Buy
+286
New +$5.59K ﹤0.01% 354

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Magnus Financial Group's ZSAN Position: Q1 2021 in Review

Magnus Financial Group sold out of Zosano Pharma Corporation (ZSAN) in Q1 2021, closing a stake of 286 shares — an estimated $5K sold.

Magnus Financial Group first reported a position in ZSAN in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 35 funds tracked by Wall St. Rank hold ZSAN as of Q1 2021.

  • Magnus Financial Group reported no remaining Zosano Pharma Corporation position as of Q1 2021 after selling out during the quarter.
  • Magnus Financial Group sold 286 Zosano Pharma Corporation shares in Q1 2021, an estimated $5K.
  • Magnus Financial Group first reported a position in Zosano Pharma Corporation in Q4 2020 and held it in 1 quarter.
  • Magnus Financial Group's Zosano Pharma Corporation position peaked at $5K in Q4 2020.
  • 35 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2021.

Based on Magnus Financial Group's 13F filing for Q1 2021, filed 5 May 2021.